Medication info
Covis Tablet 10/6.25 mg

Covis Tablet 10/6.25 mg

Prescription medicationTabletOral
Ingredient · strength
Bisoprolol Fumarate›10mg / 1 tabletHydrochlorothiazide›6.25mg / 1 tablet
Manufacturer / importer
Aju Pharmaceutical Co., Ltd.
Appearance
Orange round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200400729 · Notified 2004.12.24 · Insurance code 654001520

Summary

Main use
Treatment of hypertension
Who takes it
Adults · Children
Adult dose
This drug may be substituted for patients whose blood pressure is not controlled with 2.5-20mg of bisoprolol fumarate or for patients whose blood pressure is controlled with 50mg of hydrochlorothiazide but who experience potassium loss. The initial dose is bisoprolol fumarate/hydrochlorothiazide 2.5/6.25 milligrams once daily. Adjust the dose at 14-day intervals according to the patient's response; the maximum daily dose is bisoprolol fumarate/hydrochlorothiazide 20/12.5 milligrams. If treatment with this drug is to be discontinued, gradually reduce the dose over a period of 2 weeks or longer, depending on the patient's condition. · Patients with renal impairment : Not recommended for patients with severe renal impairment (creatinine clearance < 40mL/min). No dose adjustment is necessary in patients with renal impairment and creatinine clearance of 40mL/min or greater. · Patients with hepatic impairment : This drug should not be used in patients with severe hepatic impairment. No dose adjustment is necessary in patients with mild or moderate hepatic impairment, but use with caution. · Elderly patients : No dose adjustment is necessary in the absence of apparent renal or hepatic impairment.
Child dose
· Children : No experience with use.

Ingredients

Manufacturer
Aju Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension

  • Hypertension
View approved original text

This medication is used to control blood pressure in patients with hypertension.

How to take

Adult dose

This drug may be substituted for patients whose blood pressure is not controlled with 2.5-20mg of bisoprolol fumarate or for patients whose blood pressure is controlled with 50mg of hydrochlorothiazide but who experience potassium loss. The initial dose is bisoprolol fumarate/hydrochlorothiazide 2.5/6.25 milligrams once daily. Adjust the dose at 14-day intervals according to the patient's response; the maximum daily dose is bisoprolol fumarate/hydrochlorothiazide 20/12.5 milligrams. If treatment with this drug is to be discontinued, gradually reduce the dose over a period of 2 weeks or longer, depending on the patient's condition. · Patients with renal impairment : Not recommended for patients with severe renal impairment (creatinine clearance < 40mL/min). No dose adjustment is necessary in patients with renal impairment and creatinine clearance of 40mL/min or greater. · Patients with hepatic impairment : This drug should not be used in patients with severe hepatic impairment. No dose adjustment is necessary in patients with mild or moderate hepatic impairment, but use with caution. · Elderly patients : No dose adjustment is necessary in the absence of apparent renal or hepatic impairment.

Child dose

· Children : No experience with use.

Precautions

This medication should generally not be administered to patients with bronchospastic lung diseases. However, as it acts selectively on β1 receptors, it may be used at a low dose with caution, only in cases where other treatments are ineffective. Allergic reactions or hypersensitivity may occur, and caution is especially warranted in patients with psoriasis or a history of psoriasis. In patients with hyperthyroidism, this medication may mask symptoms, and abrupt discontinuation may worsen the condition, so it should not be stopped suddenly. Patients with hypersensitivity to any of the components of this medication, significant impairment of heart, kidney, or liver function, pregnant women, and children should not be administered this medication. Patients with specific heart or lung conditions such as congestive heart failure, atrioventricular block, severe hypotension, or chronic obstructive pulmonary disease, asthma, etc., should use this medication with special caution. Various side effects may occur with this medication, including bradycardia, hypotension, dyspnea, skin rash, gastrointestinal symptoms, etc. If such symptoms occur, immediate consultation with a healthcare provider is advised. When used for extended periods, regular monitoring of heart function, blood pressure, and liver and kidney function is necessary, and abrupt discontinuation is not recommended; dosage should be gradually reduced under a doctor's guidance. This medication may interact with other drugs, so any other medications currently being taken should be reported to a healthcare provider. Pregnant or breastfeeding women are advised to avoid this medication and must consult a doctor if necessary. Safety has not been established for pediatric use, and it is principle not to use in children. Elderly patients should start with a low dose and be closely monitored. In cases of overdose, symptoms such as bradycardia, hypotension, bronchospasm, heart failure, and hypoglycemia may occur, requiring immediate emergency treatment. During treatment with this medication, care should be taken to avoid excessive sun exposure, and any skin abnormalities should be reported to a healthcare provider.

Side effects

Bradycardia, cardiomegaly, atrioventricular block, hypotension, palpitations, heart failure, atrial fibrillation, chest pain, intermittent claudication, worsening of Raynaud's disease, sensory disturbances in the limbs, headache, feeling of heaviness in the head, dizziness, orthostatic dysregulation, drowsiness, insomnia, sensory reduction, nausea, vomiting, discomfort in the stomach, loss of appetite, diarrhea, thirst, constipation, abdominal pain, dyspnea, bronchospasm, cough, pharyngitis, rhinitis, sinusitis, rash, skin itching, decreased tear production, psoriasis, psoriasiform lesions, visual impairment, ocular paralysis, tinnitus, ear pain, taste disturbance, lethargy, weakness, dysphoria, edema, fatigue, limb coldness, chills, myalgia, sweating, numbness, weight gain, erectile dysfunction, hypokalemia, hyponatremia, hypomagnesemia, hypochloremic alkalosis, hypercalcemia, hyperuricemia, hyperglycemia, increased cholesterol, increased triglycerides, abdominal discomfort, abdominal colic, pancreatitis, sialadenitis, dry mouth, stomach pain, emotional blunting, orthostatic hypotension, arrhythmia, necrotizing vasculitis, urticaria, facial flushing, photosensitivity, anaphylaxis, increased BUN, increased creatinine, acute renal failure, interstitial nephritis, choroidal effusion, acute respiratory distress syndrome (ARDS)

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain storage temperatures between 1°C and 30°C to preserve the medication's effectiveness.

Appearance and packaging

Appearance

Orange round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.